Clinical Trials Browser

Gefitinib × 30 days × Clear all

NCT03758287 2026-05-12

Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung